Deals
Explore the dynamic landscape of pharma deals, mergers, acquisitions, and partnerships. Stay informed about strategic collaborations, licensing agreements, and investments shaping the industry. Get insights into the business side of pharmaceuticals and discover the key players driving innovation and growth.
Pfizer and Flagship sign a $7 billion strategic level R&D agreement
Source – Pfizer Pfizer has formed a significant partnership with venture capital firm Flagship Pioneering, worth up to $7 billion, ...
Phreesia Acquires MediFind to Enhance Patient Experience and Outcomes
Phreesia, a software as a service (SaaS) firm specializing in life sciences and healthcare, has announced its acquisition of MediFind, ...
Big Health Acquires Limbix, a DTx Developer for Teen Depression
Source – Big Health In a move to further consolidate its position in the digital therapeutics (DTx) sector, Big Health ...
Novartis Acquires DTx Pharma to Boost xRNA Platform and Neuroscience Pipeline
Source – Novartis On July 17, Novartis made an announcement regarding its recent acquisition of DTx Pharma, a biotechnology company ...
Lilly’s Acquisition of Versanis Aims to Enhance Patient Outcomes in Cardiometabolic Diseases
Source – Eli Lilly Eli Lilly and Versanis Bio have reached a definitive agreement for Lilly to acquire Versanis, a ...
Roche’s Potential $7billion Acquisition: Exploring the Purchase of Roivant’s Promising Drug
According to media reports, Roche is said to be in the final stages of negotiations with Roivant for a potential ...
To increase treatment and adherence rates for children with HIV in low- and middle-income countries, Gilead collaborates with CHAI and Penta
Source – Gilead Sciences Gilead Sciences is pleased to announce two collaborative initiatives. The first initiative aims to expedite the ...
BMS purchases the Prothena Alzheimer’s medication in a $2.2 billion transaction
Source: Prothena Bristol-Myers Squibb has taken an option on a tau protein-targeting antibody in early-stage clinical development from Prothena on ...
After extending its Pfizer collaboration, Samsung Biologics signs a $391M manufacturing agreement with Novartis
Shortly after finalizing two deals worth $897 million with Pfizer, Samsung Biologics has expanded its partnership with Novartis, adding hundreds ...
Moderna to research and manufacture mRNA meds in China under $1B agreement
Despite ongoing political tensions between the United States and China, foreign investments in the pharmaceutical sector are progressing in China. ...
Sanofi teams up with local pharma firms for vaccine production in Saudi Arabia
Following recent developments by AstraZeneca and National Resilience in the United Arab Emirates, Sanofi has emerged as the next major ...
Novartis Divests Xiidra and Other Ophthalmology Assets to Bausch + Lomb for $2.5 Billion
Source – Novartis In a strategic move to concentrate on its core areas, Novartis has decided to transfer the dry ...
Sigilon Therapeutics will be acquired by Lilly
Source – Eli Lilly On June 29, 2023 Eli Lilly and Company and Sigilon Therapeutics entered into a definitive agreement, ...
Bellus Health Acquired by GSK is complete
Source – GSK On 28 June 2023, GSK and BELLUS Health announced the completion of GSK’s acquisition of BELLUS through ...
Dementia Solutions: Eisai, Gates, UK Health & Univ. Edinburgh
Source – Eisai On June 29, 2023, Eisai, Gates Ventures, Health Data Research UK, LifeArc, and The University of Edinburgh ...
Vertex and Lonza Partner for New Cell Therapy Manufacturing Facility, Creating Job Opportunities
Source – Vertex Pharmaceuticals With promising developments in its experimental cell therapy VX-880 for type I diabetes, Vertex Pharmaceuticals is ...
DICE Therapeutics will be acquired by Lilly in order to advance immunology innovation
Source – Eli Lilly On June 20, 2023 a formal deal for Lilly to purchase DICE was announced by Eli ...
Merck Completes Acquisition of Prometheus Biosciences, Expanding Pipeline with Potential Breakthrough Treatment
Source: Merck On June 16, 2023, Merck announced the successful completion of its acquisition of Prometheus Biosciences, making Prometheus a ...
Pfizer updates papers for its $43 billion acquisition of Seagen as the FTC keeps a watch on biopharma M&A deals
Source: Pfizer A month later, Pfizer withdrew its notice for its proposed $43 billion acquisition of cancer medication expert Seagen ...
Novartis has agreed to purchase Chinook Therapeutics for USD 3.2 billion upfront (USD 40 per share), strengthening its new medicines strategy and renal portfolio in the process
On 12 June 2023 Novartis revealed that it has reached a deal to purchase Chinook Therapeutics, a clinical-stage biopharmaceutical business ...
AstraZeneca Enters $2 Billion Deal with Quell for Treg Cell Therapy
British start-up Quell Therapeutics has secured a collaboration with AstraZeneca focused on cell therapies for autoimmune diseases, with an upfront ...
Samsung Biologics Secures $411 Million Long-Term Deal with Pfizer for Biosimilar Production
South Korea’s Samsung Biologics has recently entered into another significant manufacturing agreement, this time with Pfizer, worth $411 million. The ...
Lonza Bolsters Antibody-Drug Conjugates Portfolio with Synaffix Acquisition
Lonza, a global manufacturing company acquired Synaffix B.V., a biotechnology company specializing in the advancement of ADCs (antibody-drug conjugates) through ...
